It depends on the standard you follow. As of September 2026, Thermo Fisher Scientific Inc. (TMO) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 16.9% / 30% · (Cash+Inv) / Mkt Cap (36m) 2.48% / 30% · Interest income / Revenue 2.08% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 16.9% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 2.48% / 33% · Receivables / Mkt Cap (36m) 3.94% / 49% · Interest income / Revenue 2.08% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 16.9% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 2.48% / 33.33% · Receivables / Mkt Cap (24m) 3.94% / 33.33% · Interest income / Revenue 2.08% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 36.9% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 5.21% / 33.33% · Receivables / Avg Assets (4Q) 8.99% / 33.33% · Interest income / Revenue 2.08% / 5% | Fail |
| FTSE | Debt / Total Assets 36.2% / 33.33% · (Cash+ST Inv) / Total Assets 5.31% / 33.33% · (Cash+Recv) / Total Assets 13.7% / 33.33% · Interest income / Revenue 2.08% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Thermo Fisher Scientific Inc. (TMO) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Thermo Fisher Scientific Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 2.08% of each dividend: Thermo Fisher Scientific Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 26, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Thermo Fisher Scientific Inc. (NYSE: TMO) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $256.1B. The Maz Rating grades it against the other companies in its sector.
Thermo Fisher Scientific Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $691.33, Thermo Fisher Scientific Inc. trades at 36.4x trailing earnings, 5.4x sales and 4.7x book value, with an EV/EBITDA of 26.0. Over the last twelve months it generated about $47.4B of revenue and $7.0B of net income. It runs a gross margin of 41.4%, an operating margin of 18.0% and a net margin of 15.0%. It shows return on equity of 13.3%, return on invested capital of 7.5% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 0.76 and a current ratio of 1.81. Over the past 52 weeks the share price ranged from $435.27 to $727.56, with a beta of 0.84.
Thermo Fisher Scientific Inc. pays a dividend yielding 0.27%, with 10% of earnings paid out. Its Maz Dividend Score is 4.17 out of 5, ranked against the other dividend payers in its sector (Safety 4.37, Growth 4.50, Yield 1.23, Consistency 2.93).
43 Wall Street analyst ratings cover the stock: 36 Buy and 7 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.